Skip to main content
. 2018 Apr 17;9(29):20658–20669. doi: 10.18632/oncotarget.25057

Table 4. DEmiRNAs found in the discovery phase for MIBC analysed in the TCGA dataset.

ID miRNA (present study) ID miRNA (TCGA) Mean read counts log2 Fold Change adj P (Bonferroni) adj P
(FDR)
miR-30a-5p miR-30a 179888 –2.496 5.28045E–21 1.26467E–19
miR-21-5p miR-21 854585 1.717 9.28451E–09 1.9336E–08
miR-106b-3p miR-106b 2614 1.091 9.0971E–06 7.14346E–06
let-7c-5p let-7c 27205 –1.896 0.0002 8.76786E–05
miR-7-1-5p miR-7-1 93 0.968 0.0005 0.0002
miR-205-5p miR-205 25289 1.956 0.0049 0.0015
miR-25-3p miR-25 47417 0.656 0.0801 0.0165
miR-486-5p# miR-486-2# 475 –0.645 1.8177 0.2466
miR-486-5p# miR-486-1# 473 –0.593 2.3635 0.3102
miR-451a miR-451a 3849 –0.221 6.7117 0.7409
miR-146a-5p miR-146a 482 –0.058 8.8212 0.9087

Abbreviations: FDR false discovery rate, MIBC muscle-invasive bladder cancer.

Significant results in bold.

#for this miRNA it was not possible to distinguish the locus.